SOCIUM Company
SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months. By taking a systems biology approach using our Augmented intelligence and Machine Learning – instead of hypothesizing the mechanism of a disease and focusing on only a few related compounds, we profile the entire disease by analyzing various OMICS data.
Founded Date:
2017-09-01
Last Funding Date:
2018-10-12
Industry:
Quantum Biology
Total Funding:
2362077
Headquarters:
Tokyo,Tokyo,Japan,Asia
Employee Number:
11-50
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
260000000
Last Funding Total Usd:
623814
Last Funding Total Currency:
JPY
Last Funding Total Value:
70000000
Founders:
Katsuhisa Horimoto,Manabu Takahashi
Phone Number:
+81 03-6869-7996